A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1007/BF02725338.pdf
Reference21 articles.
1. Schwartz GJ, Mehta RH, Wenig BL, et al. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.Head Neck 2000;22:34–41.
2. Pearlman NW. Treatment outcome in recurrent head and neck cancer.Arch Surg 1979;114:39–42.
3. Jones KR, Lodge-Rigal RD, Reddick RL, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity.Arch Otolaryngol Head Neck Surg 1992;118:483–5.
4. Fu KK, Lichter A, Galante M. Carcinoma of the floor of the mouth: an analysis of treatment results and the sites and causes of failures.Int J Radiat Oncol Biol Phys 1976;1:829–37.
5. Paredes J, Hong W, Felder T, et al. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocaramate in recurrent and/or metastatic squamous cell cancer of the head and neck.J Clin Oncol 1988;6:955–62.
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05
2. Review of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy;Human Gene Therapy;2023-04-01
3. Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma;Frontiers in Cell and Developmental Biology;2022-08-26
4. Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20;Viruses;2021-05-08
5. B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma;Journal of Cancer Research and Clinical Oncology;2020-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3